Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RCL vs MRNA✓SelectedUSD · MRNARCL vs MRNA performance historyLatest closeAs of+4.31%11/18
Stock and ETF performance explorer

RCL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13.7%
MRNA return
-9.4%
Excess return
+23.1%
Maximum drawdown
-9.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+4.3%-4.8%+9.2%+5.6%
7D-4.3%-20.9%+16.5%+1.9%
30D+13.7%-13.3%+27.0%+17.1%
All+13.7%-9.4%+23.1%+17.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1mo analysis · Full analysis span regression · Available span rolling